Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Injectco vs Livv

Injectco
Graded #241

Lower grade

vs+0.30000000000001137
Livv
Graded #237

Higher grade

The verdict

Livv takes it — 64.9/100 to 64.6/100, but only just.

Livv grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth weight loss provider offering compounded tirzepatide programs. Injectco is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLivv +4
72
76
Dose & formulationEven
64
64
Clinical oversightEven
71
71
Labs & monitoringInjectco +1
53
52
FulfillmentLivv +5
60
65
Contract termsInjectco +14
55
41
Injectco · left barLivv · right bar

The numbers

MetricInjectcoLivv
WeighScore64.6/10064.9/100
GradeCC
Scorecard rank#241#237
Semaglutide$156/mo (compounded)$135/mo (starting dose, compounded)
Tirzepatide$425/mo (starting dose, compounded)$249/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Injectco

Graded #241 · C

Strengths

  • Physical address in Dallas TX
  • Founded July 2021 — established
  • Bulk pricing ($1,249 for 6-8 months) can be cost-effective
  • Payment plan available ($156/mo)

Where it loses points

  • Does not specify which GLP-1 drug (semaglutide vs tirzepatide)
  • No LegitScript or PCAB accreditation
  • Primarily a medspa (Botox, fillers, hair restoration)
  • May be Texas-only — unclear if telehealth ships nationally
  • No named pharmacy partners
Livv

Graded #237 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard